Skip to main content
. 2015 Aug 18;10(8):e0135441. doi: 10.1371/journal.pone.0135441

Fig 1. Average IL-6 levels in MS patients.

Fig 1

(A) Average IL-6 levels in patients with the three indicated IL-6 genotypes. (B) Average IL-6 levels in patients bearing at least one allele with a C at position -174 of IL-6 gene and in those bearing only the allele with the G at the same position. 0 = samples collected just before the beginning of IFNβ-1a therapy; 1 = samples collected at about 12 hours after the first injection; 12 = samples collected at about 12 hours (h) from the injection performed at 12 weeks of therapy.